These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 39018867
41. Articular degeneration after subchondral cementation for giant cell tumors at the knee. Wechsler C, Hodel S, Stern C, Laux CJ, Rosskopf AB, Müller DA. Surg Oncol; 2022 Sep; 44():101817. PubMed ID: 36122451 [Abstract] [Full Text] [Related]
43. Curettage as first surgery for bone giant cell tumor : adequate surgery is more important than oncology training or surgical management by high volume specialized teams. Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Akahane M, Tanaka Y, Errani C. Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):3-9. PubMed ID: 31520122 [Abstract] [Full Text] [Related]
45. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum. Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J. Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753 [Abstract] [Full Text] [Related]
47. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups). Gouin F, Dumaine V, French Sarcoma and Bone Tumor Study Groups GSF-GETO. Orthop Traumatol Surg Res; 2013 Oct 01; 99(6 Suppl):S313-8. PubMed ID: 23978709 [Abstract] [Full Text] [Related]
48. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint. Duan DK, Zhang GC, Sun BJ, Ma TX, Zhao M. Eur Rev Med Pharmacol Sci; 2023 Jun 01; 27(11):5039-5052. PubMed ID: 37318478 [Abstract] [Full Text] [Related]
50. Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision. van der Heijden L, van de Sande MA, van der Geest IC, Schreuder HW, van Royen BJ, Jutte PC, Bramer JA, Öner FC, van Noort-Suijdendorp AP, Kroon HM, Dijkstra PD. Eur Spine J; 2014 Sep 01; 23(9):1949-62. PubMed ID: 24614982 [Abstract] [Full Text] [Related]
51. Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation. Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Righi A, Akahane M, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C. J Surg Oncol; 2019 Jun 01; 119(7):864-872. PubMed ID: 30734307 [Abstract] [Full Text] [Related]
54. Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization. Ming Z, Kangwu C, Huilin Y, Genlin W, Jian L, Yiming J, Chunshen W, Chao C. Turk Neurosurg; 2013 Jun 01; 23(5):645-52. PubMed ID: 24101313 [Abstract] [Full Text] [Related]
56. Long-term clinical outcome of sacral chondrosarcoma treated by total en bloc sacrectomy and reconstruction of lumbosacral and pelvic ring using intraoperative extracorporeal irradiated autologous tumor-bearing sacrum: a case report with 10 years follow-up. Nishizawa K, Mori K, Saruhashi Y, Takahashi S, Matsusue Y. Spine J; 2014 May 01; 14(5):e1-8. PubMed ID: 24262861 [Abstract] [Full Text] [Related]
58. Surgical treatment for pelvic giant cell tumor: a multi-center study. Zheng K, Yu X, Hu Y, Wang Z, Wu S, Ye Z. World J Surg Oncol; 2016 Apr 05; 14():104. PubMed ID: 27044392 [Abstract] [Full Text] [Related]